Stock Taper 
CORMORANT ASSET MANAGEMENT, LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Roivant Sciences Ltd. | ROIV | 475K | $16.81M |
 Definium Therapeutics, Inc. | DFTX | 400K | $18.82M |
 Spyre Therapeutics, Inc. | SYRE | 225K | $19.98M |
 Amylyx Pharmaceuticals, Inc. | AMLX | 200K | $3.59M |
 Arcutis Biotherapeutics, Inc. | ARQT | 175K | $4.59M |
 Odyssey Therapeutics, Inc. | ODTX | 175K | $3.27M |
 Enliven Therapeutics, Inc. | ELVN | 150K | $7.61M |
 Crinetics Pharmaceuticals, Inc. | CRNX | 125K | $4.68M |
 Cogent Biosciences, Inc. | COGT | 100K | $3.87M |
 Tarsus Pharmaceuticals, Inc. | TARS | 100K | $6.29M |
 Insmed Incorporated | INSM | 75K | $8M |
 Ascendis Pharma A/S | ASND | 50K | $13.34M |
 Arrowhead Pharmaceuticals, Inc. | ARWR | 50K | $4.08M |
 Vaxcyte, Inc. | PCVX | 50K | $2.91M |